Structural and Functional Analysis of the Cdk13/Cyclin K Complex

Cell Reports

Volumn 14, Issue 2, 2016, Pages 320-331

  Greifenberg, Ann Katrin ^a,b   Hönig, Dana ^b,c   Pilarova, Kveta ^d   Düster, Robert ^a,b   Bartholomeeusen, Koen ^d   Bösken, Christian A ^b,c   Anand, Kanchan ^a,e   Blazek, Dalibor ^d   Geyer, Matthias ^a,b,c  

^a UNIVERSITY OF BONN   (Germany)

^b CENTER OF ADVANCED EUROPEAN STUDIES AND RESEARCH CAESAR   (Germany)

^c MAX PLANCK INSTITUTE OF MOLECULAR PHYSIOLOGY   (Germany)

^d MASARYK UNIVERSITY   (Czech Republic)

^e EUROPEAN MOLECULAR BIOLOGY LABORATORY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; CYCLIN DEPENDENT KINASE; CYCLIN DEPENDENT KINASE 12; CYCLIN DEPENDENT KINASE 13; CYCLIN DEPENDENT KINASE 9; CYCLIN K; PEPTIDYLPROLYL ISOMERASE PIN1; RNA POLYMERASE II; SERINE; TRANSCRIPTION ELONGATION FACTOR; UNCLASSIFIED DRUG;

ARTICLE; CARBOXY TERMINAL SEQUENCE; CRYSTAL STRUCTURE; ENZYME PHOSPHORYLATION; ENZYME SPECIFICITY; GENE EXPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN MOTIF; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; PROTEIN SUBUNIT; STRUCTURE ACTIVITY RELATION; GENETICS; METABOLISM; PHOSPHORYLATION; SIGNAL TRANSDUCTION;

CYCLIN-DEPENDENT KINASES; HUMANS; PHOSPHORYLATION; SIGNAL TRANSDUCTION;

EID: 84955368501     PISSN: None     EISSN: 22111247     Source Type: Journal    
DOI: 10.1016/j.celrep.2015.12.025     Document Type: Article

References (40)

1. Adelman K., Lis J.T. Promoter-proximal pausing of RNA polymerase II: emerging roles in metazoans. Nat. Rev. Genet. 2012, 13:720-731.
2. Allen B.L., Taatjes D.J. The Mediator complex: a central integrator of transcription. Nat. Rev. Mol. Cell Biol. 2015, 16:155-166.
3. Bartkowiak B., Greenleaf A.L. Expression, purification, and identification of associated proteins of the full-length hCDK12/CyclinK complex. J. Biol. Chem. 2015, 290:1786-1795.
4. Bartkowiak B., Liu P., Phatnani H.P., Fuda N.J., Cooper J.J., Price D.H., Adelman K., Lis J.T., Greenleaf A.L. CDK12 is a transcription elongation-associated CTD kinase, the metazoan ortholog of yeast Ctk1. Genes Dev. 2010, 24:2303-2316.
5. Baumli S., Lolli G., Lowe E.D., Troiani S., Rusconi L., Bullock A.N., Debreczeni J.E., Knapp S., Johnson L.N. The structure of P-TEFb (CDK9/cyclin T1), its complex with flavopiridol and regulation by phosphorylation. EMBO J. 2008, 27:1907-1918.
6. Baumli S., Hole A.J., Wang L.Z., Noble M.E., Endicott J.A. The CDK9 tail determines the reaction pathway of positive transcription elongation factor b. Structure 2012, 20:1788-1795.
7. Berro R., Pedati C., Kehn-Hall K., Wu W., Klase Z., Even Y., Genevière A.M., Ammosova T., Nekhai S., Kashanchi F. CDK13, a new potential human immunodeficiency virus type 1 inhibitory factor regulating viral mRNA splicing. J. Virol. 2008, 82:7155-7166.
8. Blazek D., Kohoutek J., Bartholomeeusen K., Johansen E., Hulinkova P., Luo Z., Cimermancic P., Ule J., Peterlin B.M. The Cyclin K/Cdk12 complex maintains genomic stability via regulation of expression of DNA damage response genes. Genes Dev. 2011, 25:2158-2172.
9. Bösken C.A., Farnung L., Hintermair C., Merzel Schachter M., Vogel-Bachmayr K., Blazek D., Anand K., Fisher R.P., Eick D., Geyer M. The structure and substrate specificity of human Cdk12/Cyclin K. Nat. Commun. 2014, 5:3505.
10. Buratowski S. Progression through the RNA polymerase II CTD cycle. Mol. Cell 2009, 36:541-546.
11. Integrated genomic analyses of ovarian carcinoma. Nature 2011, 474:609-615. The Cancer Genome Atlas Research Network.
12. Chen C., Ha B.H., Thévenin A.F., Lou H.J., Zhang R., Yip K.Y., Peterson J.R., Gerstein M., Kim P.M., Filippakopoulos P., et al. Identification of a major determinant for serine-threonine kinase phosphoacceptor specificity. Mol. Cell 2014, 53:140-147.
13. Chen H.R., Lin G.T., Huang C.K., Fann M.J. Cdk12 and Cdk13 regulate axonal elongation through a common signaling pathway that modulates Cdk5 expression. Exp. Neurol. 2014, 261:10-21.
14. Corden J.L. RNA polymerase II C-terminal domain: Tethering transcription to transcript and template. Chem. Rev. 2013, 113:8423-8455.
15. Czudnochowski N., Bösken C.A., Geyer M. Serine-7 but not serine-5 phosphorylation primes RNA polymerase II CTD for P-TEFb recognition. Nat. Commun. 2012, 3:842.
16. Dai Q., Lei T., Zhao C., Zhong J., Tang Y.Z., Chen B., Yang J., Li C., Wang S., Song X., et al. Cyclin K-containing kinase complexes maintain self-renewal in murine embryonic stem cells. J. Biol. Chem. 2012, 287:25344-25352.
17. Davidson L., Muniz L., West S. 3' end formation of pre-mRNA and phosphorylation of Ser2 on the RNA polymerase II CTD are reciprocally coupled in human cells. Genes Dev. 2014, 28:342-356.
18. Eick D., Geyer M. The RNA polymerase II carboxy-terminal domain (CTD) code. Chem. Rev. 2013, 113:8456-8490.
19. Eifler T.T., Shao W., Bartholomeeusen K., Fujinaga K., Jäger S., Johnson J.R., Luo Z., Krogan N.J., Peterlin B.M. Cyclin-dependent kinase 12 increases 3' end processing of growth factor-induced c-FOS transcripts. Mol. Cell. Biol. 2015, 35:468-478.
20. Ekumi K.M., Paculova H., Lenasi T., Pospichalova V., Bösken C.A., Rybarikova J., Bryja V., Geyer M., Blazek D., Barboric M. Ovarian carcinoma CDK12 mutations misregulate expression of DNA repair genes via deficient formation and function of the Cdk12/CycK complex. Nucleic Acids Res. 2015, 43:2575-2589.
21. Ghamari A., van de Corput M.P., Thongjuea S., van Cappellen W.A., van Ijcken W., van Haren J., Soler E., Eick D., Lenhard B., Grosveld F.G. In vivo live imaging of RNA polymerase II transcription factories in primary cells. Genes Dev. 2013, 27:767-777.
22. Ghosh G., Adams J.A. Phosphorylation mechanism and structure of serine-arginine protein kinases. FEBS J. 2011, 278:587-597.
23. Grünberg S., Hahn S. Structural insights into transcription initiation by RNA polymerase II. Trends Biochem. Sci. 2013, 38:603-611.
24. Hanes S.D. The Ess1 prolyl isomerase: traffic cop of the RNA polymerase II transcription cycle. Biochim. Biophys. Acta 2014, 1839:316-333.
25. Itzen F., Greifenberg A.K., Bösken C.A., Geyer M. Brd4 activates P-TEFb for RNA polymerase II CTD phosphorylation. Nucleic Acids Res. 2014, 42:7577-7590.
26. Kwiatkowski N., Zhang T., Rahl P.B., Abraham B.J., Reddy J., Ficarro S.B., Dastur A., Amzallag A., Ramaswamy S., Tesar B., et al. Targeting transcription regulation in cancer with a covalent CDK7 inhibitor. Nature 2014, 511:616-620.
27. Johnson L.N., Lewis R.J. Structural basis for control by phosphorylation. Chem. Rev. 2001, 101:2209-2242.
28. Joshi P.M., Sutor S.L., Huntoon C.J., Karnitz L.M. Ovarian cancer-associated mutations disable catalytic activity of CDK12, a kinase that promotes homologous recombination repair and resistance to cisplatin and poly(ADP-ribose) polymerase inhibitors. J. Biol. Chem. 2014, 289:9247-9253.
29. Larochelle S., Amat R., Glover-Cutter K., Sansó M., Zhang C., Allen J.J., Shokat K.M., Bentley D.L., Fisher R.P. Cyclin-dependent kinase control of the initiation-to-elongation switch of RNA polymerase II. Nat. Struct. Mol. Biol. 2012, 19:1108-1115.
30. Liang K., Gao X., Gilmore J.M., Florens L., Washburn M.P., Smith E., Shilatifard A. Characterization of human cyclin-dependent kinase 12 (CDK12) and CDK13 complexes in C-terminal domain phosphorylation, gene transcription, and RNA processing. Mol. Cell. Biol. 2015, 35:928-938.
31. Malumbres M., Barbacid M. Cell cycle, CDKs and cancer: a changing paradigm. Nat. Rev. Cancer 2009, 9:153-166.
32. Peterlin B.M., Price D.H. Controlling the elongation phase of transcription with P-TEFb. Mol. Cell 2006, 23:297-305.
33. Russo A.A., Jeffrey P.D., Pavletich N.P. Structural basis of cyclin-dependent kinase activation by phosphorylation. Nat. Struct. Biol. 1996, 3:696-700.
34. Schiene-Fischer C., Aumüller T., Fischer G. Peptide bond cis/trans isomerases: a biocatalysis perspective of conformational dynamics in proteins. Top. Curr. Chem. 2013, 328:35-67.
35. Schulze-Gahmen U., Upton H., Birnberg A., Bao K., Chou S., Krogan N.J., Zhou Q., Alber T. The AFF4 scaffold binds human P-TEFb adjacent to HIV Tat. eLife 2013, 2:e00327.
36. St Amour C.V., Sansó M., Bösken C.A., Lee K.M., Larochelle S., Zhang C., Shokat K.M., Geyer M., Fisher R.P. Separate domains of fission yeast Cdk9 (P-TEFb) are required for capping enzyme recruitment and primed (Ser7-phosphorylated) Rpb1 carboxyl-terminal domain substrate recognition. Mol. Cell. Biol. 2012, 32:2372-2383.
37. Wang S., Fischer P.M. Cyclin-dependent kinase 9: a key transcriptional regulator and potential drug target in oncology, virology and cardiology. Trends Pharmacol. Sci. 2008, 29:302-313.
38. Xu Y.X., Manley J.L. Pin1 modulates RNA polymerase II activity during the transcription cycle. Genes Dev. 2007, 21:2950-2962.
39. Xu Y.X., Hirose Y., Zhou X.Z., Lu K.P., Manley J.L. Pin1 modulates the structure and function of human RNA polymerase II. Genes Dev. 2003, 17:2765-2776.
40. Zhou Z., Fu X.D. Regulation of splicing by SR proteins and SR protein-specific kinases. Chromosoma 2013, 122:191-207.